Aegon sells remaining US life reinsurance business to SCOR
Dutch insurance group Aegon has agreed to divest the last substantial block of its life reinsurance business to SCOR Global Life.
The transaction is a part of Aegon’s strategic objective to reduce the amount of capital allocated to its run-off businesses.
Under the agreement, Aegon’s Transamerica life subsidiaries will reinsure approximately $700 million of liabilities through SCOR Global Life. The transaction covers the last substantial block of life reinsurance business that Transamerica retained after it divested the vast majority of its reinsurance business to SCOR Global Life in 2011 and 2017.
Aegon expects the transaction to provide a one-time benefit of approximately $50 million on Transamerica’s capital position and a slightly positive effect on recurring capital generation.
The insurer said the future underlying earnings are not affected by this transaction as earnings of this block of reinsurance business are part of run-off businesses, which are not included in underlying earnings before tax. The transaction is expected to result in a pre-tax IFRS loss of approximately $105 million and will be reported in other charges in the second half 2018 results.
As a result of the transaction, Aegon said it will significantly reduce the size of a related captive insurance company and the related letter of credit facility in place to finance redundant reserves, generally referred to as XXX term life insurance reserves.
Get all the latest re/insurance industry news with our daily newsletter - sign up here.
More of today's news
Munich Re shrinks reinsurance business in Q2
Aspen elevates CUO to lead reinsurance as CEO Lillelund resigns
Travelers replaces CFO as Benet steps down from top position
S&P warns on Swiss Re ReAssure ratings as parent ponders IPO
Zurich reveals new Canada CEO, chief agent
Munich Re grows 42% at July renewals
Revenues up at White Mountains but profits dip
Hastings Group overcomes hurdles to post strong H1 results
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Elliot Field at efield@newtonmedia.co.uk or Adrian Tapping at atapping@newtonmedia.co.uk
Editor's picks
Editor's picks
More articles
Copyright © intelligentinsurer.com 2024 | Headless Content Management with Blaze